Skip to main content
Clinical Trials/NCT02198625
NCT02198625
Unknown
Phase 4

Influence of Moderate Inspired Oxygen Fraction (FiO2) and Protective Ventilation on Postoperative Pulmonary Complication

Fenmei Shi1 site in 1 country280 target enrollmentMarch 2014
ConditionsHepatectomy

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Hepatectomy
Sponsor
Fenmei Shi
Enrollment
280
Locations
1
Primary Endpoint
a composite of pulmonary and extrapulmonary complications occurring by day 7 after surgery.
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to determine the influence of moderate FiO2 and the lung protective ventilation on postoperative pulmonary complications following hepatic resection surgery.

Registry
clinicaltrials.gov
Start Date
March 2014
End Date
June 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Fenmei Shi
Responsible Party
Sponsor Investigator
Principal Investigator

Fenmei Shi

resident

First Affiliated Hospital, Sun Yat-Sen University

Eligibility Criteria

Inclusion Criteria

  • ASA 1\~2,Planned intrabdominal hepatic resection surgery;
  • Expected duration 2 hours to 6 hours;
  • Age 40 yr to 70 yr);
  • BMI 18-26.9kg/m2
  • Risk of postoperative pulmonary complications (Arozullah score ≥2);

Exclusion Criteria

  • Noninvasive ventilation in the last 30 days;
  • Recent history of pneumonia, ALI/ARDS (in the last 30 days);
  • History of pulmonary resection;
  • History of neuromuscular disease;
  • Child-Pugh\>A grade;
  • Patient refusal;

Outcomes

Primary Outcomes

a composite of pulmonary and extrapulmonary complications occurring by day 7 after surgery.

Time Frame: during the first seven days after surgery

The primary outcome was a composite of major pulmonary complications (defined as pneumonia or need for invasive or noninvasive ventilation for acute respiratory failure) and extrapulmonary complications (defined as sepsis, septic shock, or death) within the first 7 days after surgery.

Secondary Outcomes

  • incidence of pulmonary complications(within the 30-day follow-up period)
  • Oxidative stress markers(2 days)

Study Sites (1)

Loading locations...

Similar Trials